• Home   /  
  • Archive by category "1"

Legalizing Cannabis Research Paper

Please, wait while we are validating your browser

1. Silins E, Horwood LJ, Patton GC, et al. Cannabis Cohorts Research Consortium. Young adult sequelae of adolescent cannabis use: an integrative analysis. Lancet Psychiatry. 2014;1:286–93.[PubMed]

2. George TP, Vaccarino F. The effects of cannabis use during adolescence. Canadian Centre on Substance Abuse; 2015. [accessed 2015 June 9]. Available: www.ccsa.ca/Resource%20Library/CCSA-Effects-of-Cannabis-Use-during-Adolescence-Report-2015-en.pdf.

3. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109:E2657–64.[PMC free article][PubMed]

4. Anthony JC. The epidemiology of cannabis dependence. In: Roffman RA, Stephens RS, editors. Cannabis dependence: its nature, consequences and treatment. Cambridge (UK): Cambridge University Press; 2006. pp. 58–105.

5. Bosker WM, Karschner EL, Lee D, et al. Psychomotor function in chronic daily cannabis smokers during sustained abstinence. PLoS ONE. 2013;8:e53127.[PMC free article][PubMed]

6. Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348:1786–95.[PubMed]

7. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007;9:315–27.[PubMed]

8. Pagliaccio D, Barch DM, Bogdan R, et al. Shared predisposition in the association between cannabis use and subcortical brain structure. JAMA Psychiatry. 2015;72:994–1001.[PMC free article][PubMed]

9. Zalesky A, Solowij N, Yücel M, et al. Effect of long-term cannabis use on axonal fibre connectivity. Brain. 2012;135:2245–55.[PubMed]

10. Bloomfield MAP, Morgan CJA, Egerton A, et al. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol Psychiatry. 2014;75:470–8.[PubMed]

11. Hill KP. Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review. JAMA. 2015;313:2474–83.[PubMed]

12. Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2015;110:19–35.[PubMed]

13. Di Forti M, Marconi A, Carra E, et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry. 2015;2:233–8.[PubMed]

14. Gage SH, Zammit S, Hickman M. Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 Med Rep. 2013;5:2.[PMC free article][PubMed]

15. Hickman M, Vickerman P, Macleod J, et al. If cannabis caused schizophrenia — How many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction. 2009;104:1856–61.[PubMed]

16. Gage SH, Hickman M, Heron J, et al. Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children. Psychol Med. 2014;44:3435–44.[PMC free article][PubMed]

17. Nutt DJ, King LA, Phillips LD, et al. Drug harms in the UK: a multicriteria decision analysis. Lancet. 2010;736:1558–65.[PubMed]

18. Pryce S. Fixing drugs: the politics of drug prohibition. UK: Palgrave Macmillan; 2012.

19. Room R, Fischer B, Hall W, et al. Cannabis policy: moving beyond the stalemate. Oxford (UK): Oxford University Press & The Beckley Foundation; 2010.

20. Centre for Addiction and Mental Health. Cannabis policy framework. 2014. [accessed 2015 Oct. 7]. Available: www.camh.ca/en/hospital/about_camh/influencing_public_policy/Documents/CAMHCannabisPolicyFramework.pdf.

21. Khenti A. The Canadian war on drugs: structural violence and unequal treatment of black Canadians. Int J Drug Policy. 2014;25:190–5.[PubMed]

22. Werb D, Nosyk B, Kerr T, et al. Estimating the economic value of British Columbia’s domestic cannabis market: implications for provincial public policy. Int J Drug Policy. 2012;23:436–41.[PubMed]

23. Ogrodnik M, Kopp P, Bongaerts X, et al. An economic analysis of different cannabis decriminalization scenarios. Psychiatr Danub. 2015;27(Suppl 1):S309–14.[PubMed]

24. Support for marijuana legalization steady at more than half. Forum Research [website] 2015. [accessed 2015 Sept. 20]. Available: http://poll.forumresearch.com/post/1362/just-one-tenth-think-current-laws-are-appropriate/

25. Canadian Centre on Substance Abuse (CCSA) Cannabis regulation: lessons learned in Colorado and Washington State. Ottawa (ON): CCSA; 2015. [accessed 2015 Nov. 13]. Available: www.ccsa.ca/Resource%20Library/CCSA-Cannabis-Regulation-Lessons-Learned-Report-2015-en.pdf.

26. Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72:1235–42.[PMC free article][PubMed]

27. Hall W, Weier M. Assessing the public health impacts of legalizing recreational cannabis use in the USA. Clin Pharmacol Ther. 2015;97:607–15.[PubMed]

28. Canadian Centre on Substance Abuse (CCSA) Marijuana for Non-Therapeutic Purposes. Ottawa (ON): CCSA; 2014. [accessed 2015 Oct. 21]. Available: www.ccsa.ca/Resource%20Library/CCSA-Non-Therapeutic-Marijuana-Policy-Brief-2014-en.pdf.

29. 2009-11 Toyota vehicle recalls. Wikipedia [website] [accessed 2015 Sept. 20]. Available: https://en.wikipedia.org/wiki/2009-11_Toyota_vehicle_recalls.

One thought on “Legalizing Cannabis Research Paper

Leave a comment

L'indirizzo email non verrà pubblicato. I campi obbligatori sono contrassegnati *